Patents by Inventor Shamim Pushpala

Shamim Pushpala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
    Patent number: 8945592
    Abstract: Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: February 3, 2015
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Shamim Pushpala, Larry Hamel, Stelios Tzannis, Evangeline Cruz
  • Oral Transmucosal Administration of Sufentanil
    Publication number: 20110288128
    Abstract: Compositions and methods for administration of sufentanil-containing drug formulations to the oral mucosa of a subject are disclosed.
    Type: Application
    Filed: May 21, 2010
    Publication date: November 24, 2011
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Shamim Pushpala, Evangeline Cruz, Larry Hamel, Linda Judge
  • Sufentanil Solid Dosage Forms Comprising Oxygen Scavengers and Methods of Using the Same
    Publication number: 20100130551
    Abstract: Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.
    Type: Application
    Filed: November 21, 2008
    Publication date: May 27, 2010
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Shamim Pushpala, Lary Hamel, Stelios Tzannis, Evangeline Cruz
  • Implantable gel compositions and method of manufacture
    Publication number: 20060233841
    Abstract: Methods and compositions for reducing the burst of beneficial agent from implantable systems is described. Such systems utilize compressed particulates of a beneficial agent, optionally mixed with a dissolution rate modulator or an agent exhibiting a characteristic of low solubility in water, such as a mixture of stearic acid and palmitic acid, dispersed throughout a bioerodible and biocompatible carrier.
    Type: Application
    Filed: August 25, 2003
    Publication date: October 19, 2006
    Inventors: Kevin Brodbeck, Shamim Pushpala, Steven Prestrelski
  • Polymeric microporous film coated subcutaneous implant
    Patent number: 6022554
    Abstract: This invention relates to coating formulations for coating sustained-release drug implants. The coating formulations are capable of formulations are capable of forming a porous film coat over a biologically active agent to provide a release of the active agent at a constant rate over a prolonged period of time. The pore forming agent is used in the formulation of the invention in the amount effective to regulate the release of a biologically active compound at a desired rate. Preferably, the effective amount of the pore forming agent provides long term delivery of the active agent. The invention also provides an improved implant for the sustained administration of a biologically active compound suitable for subcutaneous implantation. The invention also relates to methods for making and using the formulation and the implant of the invention.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: February 8, 2000
    Assignee: American Home Products Corporation
    Inventors: Jung-Chung Lee, Shamim Pushpala, Charles E. Lee